MHRA approves the RAPID-1DFU clinical trials

MHRA approves the RAPID-1DFU clinical trials

 

 

Biotherapy Services Limited

 

MHRA approves the RAPID-1DFU clinical trial 

Company is progressing as planned towards Q1/2019 clinical trials.

8thNovember 2018, Biotherapy Services Ltd. the specialist wound healing service company, today announces that it has secured regulatory approval from the Medicines and Healthcare Regulatory Agency (MHRA) for the commencement of the RAPID-1DFU randomised controlled trial.

The RAPID-1DFU Diabetic Foot Ulcer trial is currently recruiting patients, with treatments commencing in first quarter of 2019.

 

For further information, please contact:

Biotherapy Services Ltd

Janet Hadfield, Chief Executive Officer

Info@biotherapyservices.comTel: ++44 (0) 207 788 7828